The receiver matters.

THE RF SAFE MODEL · A TESTABLE HYPOTHESIS

Sensitivity as a loss of biological signaling fidelity

RF Safe’s central proposal is that certain electromagnetic exposures could act as unwanted inputs to biological control systems. If a field couples to a relevant cellular process, it could alter the timing, amplitude or coordination of signals that cells use to regulate their activity. We call the proposed reduction in the reliability of those processes “low-fidelity biology.”

In this model, the important question is whether an exposure disrupts a meaningful biological function. “Noise” describes interference relative to that function; it can include a patterned disturbance, not only random fluctuations. “Information stressor” refers to a proposed change in the fidelity of internal signaling. It does not mean that cells interpret the messages being transmitted by a phone or router.

The model predicts that a disturbance might be buffered or compensated for in one person, yet produce measurable dysfunction in another. Candidate influences include genetic variation, current illness, sleep loss, metabolic state, concurrent chemical or environmental exposures, and the time available for recovery. These are variables to test—not established explanations for every person reporting EHS.

The research question: under what exposure, in what biological state, does signaling change enough to impair function—and does that change track symptoms and recovery? The fact that calcium timing carries biological information is established. The claim that particular everyday EMF exposures degrade that information and cause EHS remains a hypothesis requiring direct testing. [2]

Where the peanut and bee-venom analogy stops

The analogy illustrates individual susceptibility: one person’s tolerance cannot establish another person’s tolerance. RF Safe’s proposed mechanism, however, concerns field-mediated perturbation of signaling rather than an allergic response to an introduced substance.

Both are physical processes. Proteins and venom act through biochemical interactions; electromagnetic fields can interact with matter through physical coupling. The distinction is the proposed route of interaction, rather than “physical” versus “nonphysical.” For the RF Safe model, that route must connect a specified field to altered cellular dynamics and then to a meaningful functional outcome.

An allergy analogy cannot establish that route. Nor does a laboratory response to one waveform establish that every EMF exposure is disruptive, that all exposed people are harmed, or that genetic differences explain every reported sensitivity.

HUMAN EXPERIMENT · A CLUE WORTH REPLICATING

A small genetic difference. A measurable sleep response.

A 2025 randomized, double-blind, sham-controlled crossover study tested 34 volunteers: 15 with T/C and 19 with T/T at CACNA1C rs7304986, a noncoding variant in a calcium-channel gene. Participants received 30 minutes of presleep exposure under 3.6 GHz, 700 MHz and sham conditions. The researchers reported a genotype-dependent effect of 3.6 GHz exposure on sleep-spindle center frequency. [1]

The study did not edit a letter in participants’ DNA. It compared existing genotypes, so it does not establish that this particular variant is itself the causal molecular switch. Nor did it establish EHS, injury or accelerated aging. The finding supports a focused question: can genotype help explain reproducible differences in physiological response? Independent replication and a demonstrated link to symptoms or impaired function are essential. [1]

Timing is part of biological signaling.

Calcium signals carry information through their timing as well as their size. Foundational experiments showed that changing calcium-oscillation frequency and amplitude could change gene-expression responses. Ion channels, cellular metabolism and feedback systems therefore offer measurable places to investigate a timing hypothesis. [2]

Connecting these findings requires actual measurements of coupling, exposure and response. A low-frequency magnetic field and an RF signal with a low-frequency modulation envelope are different exposures. Matching a number of pulses per second is insufficient to show biological equivalence. Carrier frequency, field strength, waveform, duration, tissue distribution and experimental conditions all matter.

What existing symptom studies found matters, too.

A 2024 systematic review of 41 experimental studies involving 2,874 participants found no or small, statistically nonsignificant effects of RF exposure on symptoms. Participants reporting sensitivity did not reliably identify exposure better than chance. These studies examined symptoms as well as detection; reducing them all to “can you feel Wi-Fi?” would misrepresent their evidence. [5]

The review also acknowledged limitations concerning acute laboratory conditions, longer exposures, older or chronically ill people, and the possibility of mixed susceptibility. Those limitations motivate targeted research; they do not establish a hidden susceptible subgroup. Expectations and learned associations can contribute to genuine symptoms and belong among the explanations tested. [5]

WHO’s EHS guidance explicitly recognizes that symptoms can be real and disabling while noting that an EMF cause has not been established. Respectful care and a careful search for explanations can proceed together. [6]

A shared umbrella. Room for different explanations.

RF Safe proposes “reported EMF-related symptoms and concerns” as an inclusive organizing umbrella. People may describe themselves as electromagnetically hypersensitive, report anomalous health incidents, or believe they have been deliberately targeted. Their accounts can be considered together to look for shared symptoms and research questions while retaining their distinct histories and original descriptions.

These labels are not interchangeable diagnoses. An account of targeting describes a person’s interpretation of events; it does not independently establish a perpetrator, a device or an electromagnetic cause. AHI is also not a synonym for genetically mediated hypersensitivity.

There is a serious basis for investigating possible overlap. A 2020 National Academies assessment identified directed, pulsed RF energy as the most plausible of the mechanisms it considered for certain distinctive early AHI presentations. That assessment did not establish one cause for every case or demonstrate equivalence with everyday EHS reports. [7] In 2024, NIH studies documented significant symptoms but found no significant MRI-detectable brain injury and no differences in most clinical measures compared with controls. Those findings also did not erase the participants’ illness. [8]

A shared research umbrella should help investigators compare accounts without forcing them into a common diagnosis. This archive keeps the individual topic labels and source comments intact. Classification describes what someone reported; it does not validate a claimed cause.

ceLLM · SIGNALING, ADAPTATION & FEEDBACK

How a disturbance could become a feedback loop

In John Coates’s ceLLM framework, DNA and chromatin constrain how a cell responds, while its local biochemical, mechanical and bioelectric environment supplies changing inputs. The cell acts on those inputs, and its response changes the environment it encounters next. This is RF Safe’s proposed way of connecting cellular organization with adaptive behavior.

The low-fidelity hypothesis adds a possible failure pathway: an external field perturbs signaling; the altered response adds stress; that stress changes the cell’s internal environment; subsequent responses become less reliable. Recovery could interrupt the loop. Repeated exposure or other stressors could, in the model, increase its consequences. Each step requires evidence—observing a rhythm change alone does not demonstrate the entire chain.

RF Safe uses “meta-disease state” for the proposed upstream reduction in resilience that might influence multiple downstream outcomes. This is a framework term, not an established diagnosis, a validated aging measure or an explanation already demonstrated in the comment record. To test it, researchers must define fidelity in measurable terms, such as reproducibility of an appropriate response, coordination with a specified partner process, or recovery of function after a challenge. Healthy variability must not be mistaken for failure.

Compounding stressors and confounding factors also need separate treatment. A compounding stressor would modify or add to an exposure’s effect. A confounder could instead explain an apparent exposure–symptom association. Careful studies must be able to distinguish those possibilities and report results that contradict the model.

A CONCRETE REQUEST TO HHS

Build studies that can find—or rule out—susceptible groups.

1. Replicate the human finding. Preregister genotype-by-exposure analyses, recruit enough participants to test interactions, use calibrated dosimetry and blinded sham controls, and reproduce the sleep-spindle result independently.
2. Measure physiology and experience together. Track sleep, symptoms and relevant functional outcomes over prespecified windows. Include delayed responses where justified. A physiological change must be connected to clinical meaning before it is described as harm.
3. Characterize the exposure and the person. Record waveform, intensity, duration and timing alongside medications, sleep pressure, underlying illness and concurrent exposures. Prespecify tests of susceptibility and combined-stressor interactions, control alternative explanations, and measure recovery. Preserve symptom-free and negative observations.
4. Test mechanisms under relevant conditions. Use cellular calcium and redox measurements, genetic perturbation and rescue experiments to test causal pathways. Establish whether an effect occurs at exposures relevant to the population being studied.
5. Protect the integrity of the result. Involve affected people in study design, preserve blinding, publish null findings, distinguish exploratory subgroups from confirmed ones, and specify results that would weaken or reject the proposed mechanism.